[13-Cis-retinoic acid: a new form of treatment of rosacea (author's transl)].
13-cis-retinoic acid was given with good results to 7 patients with exceptionally severe rosacea. Side effects were transitory and of minor consequence and subsided quickly on reduction of the dosage and topical application of mild cosmetics. The long-lasting remissions recorded to date indicate that 13-cis-retinoic acid may prove a new and successful approach to the treatment of rosacea.
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D015474:Isotretinoin; D008297:Male; D008875:Middle Aged; D012393:Rosacea / Q000188:drug therapy*; D013754:Tetracyclines / Q000627:therapeutic use; D014212:Tretinoin / Q000008:administration & dosage / Q000627:therapeutic use*
D013754:Tetracyclines; D014212:Tretinoin; D015474:Isotretinoin
13-cis-Retinsäure: Eine neue Behandlungsform der Rosazea.